68Ga-PSMA-HBED-CC PET/CT: where molecular imaging has an edge over morphological imaging

被引:13
作者
Mottaghy, Felix M. [1 ,2 ]
Behrendt, Florian F. [1 ]
Verburg, Frederik A. [1 ,2 ]
机构
[1] RWTH Univ Hosp Aachen, Dept Nucl Med, Pauwelsstr 30, D-52074 Aachen, Germany
[2] Maastricht Univ, Med Ctr, Dept Nucl Med, NL-6200 MD Maastricht, Netherlands
关键词
MEMBRANE ANTIGEN-EXPRESSION; GA-68-LABELED PSMA LIGAND; PROSTATE-CANCER; RADIATION-DOSIMETRY; BIODISTRIBUTION; DIAGNOSIS; GA-68-DOTATOC; BIOKINETICS; CARCINOMA; THERAPY;
D O I
10.1007/s00259-015-3212-5
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:394 / 396
页数:3
相关论文
共 34 条
  • [1] PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions
    Afshar-Oromieh, A.
    Malcher, A.
    Eder, M.
    Eisenhut, M.
    Linhart, H. G.
    Hadaschik, B. A.
    Holland-Letz, T.
    Giesel, F. L.
    Kratochwil, C.
    Haufe, S.
    Haberkorn, U.
    Zechmann, C. M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (04) : 486 - 495
  • [2] The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor Lesions
    Afshar-Oromieh, Ali
    Hetzheim, Henrik
    Kratochwil, Clemens
    Benesova, Martina
    Eder, Matthias
    Neels, Oliver C.
    Eisenhut, Michael
    Kuebler, Wolfgang
    Holland-Letz, Tim
    Giesel, Frederik L.
    Mier, Walter
    Kopka, Klaus
    Haberkorn, Uwe
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (11) : 1697 - 1705
  • [3] The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer
    Afshar-Oromieh, Ali
    Avtzi, Eleni
    Giesel, Frederik L.
    Holland-Letz, Tim
    Linhart, Heinz G.
    Eder, Matthias
    Eisenhut, Michael
    Boxler, Silvan
    Hadaschik, Boris A.
    Kratochwil, Clemens
    Weichert, Wilko
    Kopka, Klaus
    Debus, Juergen
    Haberkorn, Uwe
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (02) : 197 - 209
  • [4] Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer
    Afshar-Oromieh, Ali
    Zechmann, Christian M.
    Malcher, Anna
    Eder, Matthias
    Eisenhut, Michael
    Linhart, Heinz G.
    Holland-Letz, Tim
    Hadaschik, Boris A.
    Giesel, Frederik L.
    Debus, Juergen
    Haberkorn, Uwe
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (01) : 11 - 20
  • [5] PET/MRI with a 68Ga-PSMA ligand for the detection of prostate cancer
    Afshar-Oromieh, Ali
    Haberkorn, Uwe
    Hadaschik, Boris
    Habl, Gregor
    Eder, Matthias
    Eisenhut, Michael
    Schlemmer, Heinz-Peter
    Roethke, Matthias C.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (10) : 1629 - 1630
  • [6] Early side effects and first results of radioligand therapy with 177Lu-DKFZ-617 PSMA of castrate-resistant metastatic prostate cancer: a two-centre study
    Ahmadzadehfar, Hojjat
    Rahbar, Kambiz
    Kuerpig, Stefan
    Boegemann, Martin
    Claesener, Michael
    Eppard, Elisabeth
    Gaertner, Florian
    Rogenhofer, Sebastian
    Schaefers, Michael
    Essler, Markus
    [J]. EJNMMI RESEARCH, 2015, 5 : 1 - 8
  • [7] Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE:: the role of associated risk factors
    Bodei, Lisa
    Cremonesi, Marta
    Ferrari, Mahila
    Pacifici, Monica
    Grana, Chiara M.
    Bartolomei, Mirco
    Baio, Silvia M.
    Sansovini, Maddalena
    Paganelli, Giovanni
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (10) : 1847 - 1856
  • [8] Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours
    Buchmann, I.
    Henze, M.
    Engelbrecht, S.
    Eisenhut, M.
    Runz, A.
    Schaefer, M.
    Schilling, T.
    Haufe, S.
    Herrmann, T.
    Haberkorn, U.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (10) : 1617 - 1626
  • [9] Chang SS, 1999, CANCER RES, V59, P3192
  • [10] Biokinetics and dosimetry in patients administered with 111In-DOTA-Tyr3-octreotide:: implications for internal radiotherapy with 90Y-DOTATOC
    Cremonesi, M
    Ferrari, M
    Zoboli, S
    Chinol, M
    Stabin, MG
    Orsi, F
    Maecke, HR
    Jermann, E
    Robertson, C
    Fiorenza, M
    Tosi, G
    Paganelli, G
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (08) : 877 - 886